<DOC>
	<DOCNO>NCT00004408</DOCNO>
	<brief_summary>OBJECTIVES : I. Assess efficacy poloxamer 188 reduce duration painful vaso-occlusive crisis patient sickle cell disease . II . Assess effect poloxamer 188 duration intensity pain , total analgesic use , length hospitalization patient .</brief_summary>
	<brief_title>Phase III Randomized Study Poloxamer 188 Vaso-Occlusive Crisis Sickle Cell Disease</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind , placebo control , multicenter study . Patients stratify accord hydroxyurea use . Patients randomize treatment poloxamer 188 placebo . Treatment begin within 12 hour presentation crisis . Patients receive poloxamer 188 placebo continuous infusion 48 hour . Pain assess , , treatment . Patients follow day 7-14 28-35 .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Sickle cell disease confirm electrophoresis high pressure liquid chromatography At least one prior document painful crisis episode great 10 crisis per year last two year Sudden onset acute pain last 412 hour involve least one site Severe crisis pain require parenteral analgesic hospitalization , within precede 2 week Prior/Concurrent Therapy Surgery : At least 2 week since prior major surgery No concurrent surgery Other : At least 2 week since prior puncture noncompressible vessel No prior therapy use poloxamer 188 No concurrent investigational drug No concurrent use nonsteroidal antiinflammatory drug Patient Characteristics Hematopoietic : No significant bleeding bleed disorder Hepatic : ALT great 2 time normal Renal : No active renal disease Creatinine great 1.0 mg/dL OR Creatinine clearance great 50 mL/min Protein le 300 mg/dL Cardiovascular : No evidence acute myocardial ischemia infarction Neurologic : At least 6 month since prior cerebrovascular accident seizure Other : Not pregnant Fertile patient must use effective contraception least 30 day treatment No history chronic bacterial osteomyelitis No history drug alcohol abuse At least 6 month since prior use illicit drug Have adequate IV access No crisis lifethreatening complication : Hepatic splenic sequestration Acute chest syndrome Aplastic crisis No known infection infection encapsulate organism No evidence septic shock Not concurrently hospitalize condition Not concurrently hypertransfusion program</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>disease-related problem/condition</keyword>
	<keyword>genetic disease dysmorphic syndrome</keyword>
	<keyword>hematologic disorder</keyword>
	<keyword>pain</keyword>
	<keyword>rare disease</keyword>
	<keyword>sickle cell anemia</keyword>
</DOC>